| Upcoming events on BIONTECH SE |
|
| 04/06/21 | | Jahr 2020 Ergebnisveröffentlichung (geplant) |
| 05/18/21 | | Q1 2021 Ergebnisveröffentlichung (geplant) |
| 08/17/21 | | Erstes Halbjahr 2021 Ergebnisveröffentlichung (geplant) |
| 11/17/21 | | Q3 2021 Ergebnisveröffentlichung (geplant) |
|
| Past events on BIONTECH SE |
|
| 01/11/21 | 07:00pm | | Biotech Showcase Investor Conference - Panel |
| 01/11/21 | 04:50pm | | JP Morgan Healthcare Conference |
| 12/02/20 | 12:30pm | | BNT162b2 Update Call |
| 11/18/20 | 02:00pm | | Wolfe Virtual Healthcare Conference |
|
| Upcoming sector events for BIONTECH SE |
|
|
| |
|
| Past sector events for BIONTECH SE |
|
|
|
|
|
| Annual results | 2019 | 2020 (e) |
Sales
M € |
Released
Forecast
Spread | 109
110
-1,6% |
497
|
Operating income
(EBITDA)
M € |
Released
Forecast
Spread | -148
-145
-1,9% |
-269
|
Operating profit
(EBIT)
M € |
Released
Forecast
Spread | -182
-167
-8,7% |
-270
|
Pre-Tax Profit
(EBT)
M € |
Released
Forecast
Spread | -179
-158
-14% |
-324
|
Net income
M € |
Released
Forecast
Spread | -179
-157
-14% |
-329
|
EPS
€ |
Released
Forecast
Spread | -0,85
-0,74
-15% |
-1,24
| | Announcement Date | 03/31/2020 | |
|
|
|
| Quarterly results | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales
M € |
Released
Forecast
Spread | 28,7
28,5
0,62% | 28,0
30,6
-8,6% | 27,7
24,5
13% | 41,8
41,5
0,58% | 67,5
51,7
30% |
310
|
592
|
1 152
|
1 430
|
2 421
|
Operating income
(EBITDA)
M € |
Released
Forecast
Spread | -28,4
-30,1
5,6% | -43,1
-32,7
-32% | -50,7
-55,0
7,8% | -72,1
-50,0
-44% | -178
-72,4
-145% |
-78,3
|
|
|
|
|
Operating profit
(EBIT)
M € |
Released
Forecast
Spread | -36,9
-38,3
3,8% | -52,9
-40,1
-32% | -59,3
-59,1
-0,38% | -80,9
-74,8
-8,1% | -186
-92,6
-101% |
12,8
|
288
|
674
|
1 155
|
2 707
|
Pre-Tax Profit
(EBT)
M € |
Released
Forecast
Spread | -30,1
-36,7
18% | -58,5
-36,2
-62% | -53,4
-51,1
-4,5% | -90,5
-61,5
-47% | -208
-73,6
-182% |
-75,6
|
293
|
680
|
1 164
|
2 722
|
Net income
M € |
Released
Forecast
Spread | -30,1
-35,3
15% | -58,2
-37,7
-54% | -53,4
-57,2
6,6% | -88,3
-58,9
-50% | -210
-90,0
-133% |
3,29
|
293
|
680
|
1 164
|
2 722
|
EPS
€ |
Released
Forecast
Spread | -0,14
-0,16
11% | -0,26
-0,17
-50% | -0,24
-0,25
4,7% | -0,38
-0,32
-20% | -0,88
-0,41
-114% |
0,16
|
1,34
|
2,91
|
4,11
|
8,18
| | Announcement Date | 11/14/2019 | 03/31/2020 | 05/12/2020 | 08/11/2020 | 11/10/2020 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
|
CureVac strikes COVID-19 vaccine alliance with Bayer |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
